The Use of Genomic Biomarkers for Check-Point Inhibitor Response Assessment: A Discussion of Two Trials and Biomarkers

Co-Moderator(s)

• 

  Lauren Ritterhouse, MD, PhD

  Senior Lab Director
  Foundation Medicine Inc
  Cambridge, Massachusetts, United States

Co-Moderator (Early Career)(s)

• 

  Jing Di, MD, PhD

  Resident Physician
  Pathology and Laboratory Medicine
  University of Kentucky
  Lexington, Kentucky, United States

Presentations:

• 2:30 PM - 3:15 PM MST

  ImmunoMATCH Biomarker Selection and Possible Advantages of Multi-Analyte Assays
  

  Speaker: Biswajit Das, PhD (he/him/his) – Frederick National Laboratory for Cancer Research- Leidos Biomedical Research Inc
• 3:15 PM - 4:00 PM MST

  A Review of NCI-MATCH ARM Z1D: Treatment of MMR Deficient Solid Tumors with Nivolumab
  

  Speaker: Paul "Mickey" Williams, PhD – NIH/NCI